SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-18-020519
Filing Date
2018-08-08
Accepted
2018-08-08 16:28:12
Documents
64
Period of Report
2018-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q clsd-10q_20180630.htm 10-Q 1227446
2 EX-10.1 clsd-ex101_147.htm EX-10.1 847109
3 EX-10.2 clsd-ex102_146.htm EX-10.2 36355
4 EX-31.1 clsd-ex311_7.htm EX-31.1 16698
5 EX-31.2 clsd-ex312_6.htm EX-31.2 16693
6 EX-32.1 clsd-ex321_8.htm EX-32.1 9014
  Complete submission text file 0001564590-18-020519.txt   5807108

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT clsd-20180630.xml EX-101.INS 1060920
8 XBRL TAXONOMY EXTENSION SCHEMA clsd-20180630.xsd EX-101.SCH 44078
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE clsd-20180630_cal.xml EX-101.CAL 50403
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE clsd-20180630_def.xml EX-101.DEF 125441
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE clsd-20180630_lab.xml EX-101.LAB 311555
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE clsd-20180630_pre.xml EX-101.PRE 234701
Mailing Address 900 NORTH POINT PARKWAY SUITE 200 ALPHARETTA 2Q 30005
Business Address 900 NORTH POINT PARKWAY SUITE 200 ALPHARETTA 2Q 30005 678-270-3631
Clearside Biomedical, Inc. (Filer) CIK: 0001539029 (see all company filings)

IRS No.: 452437375 | State of Incorp.: GA | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37783 | Film No.: 181001758
SIC: 2834 Pharmaceutical Preparations